Abstract
Summary
The global Phenylketonuria Medications and Supplements market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Phenylketonuria Medications and Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Phenylketonuria Medications and Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Phenylketonuria Medications and Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Phenylketonuria Medications and Supplements players cover Biomarin, Mead Johnson, Abbott, Nutricia, Dr. Schär, Vitaflo, Cambrooke, PKU Perspectives and Firstplay Dietary, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.
LPI (LP Information)' newest research report, the “Phenylketonuria Medications and Supplements Industry Forecast” looks at past sales and reviews total world Phenylketonuria Medications and Supplements sales in 2022, providing a comprehensive analysis by region and market sector of projected Phenylketonuria Medications and Supplements sales for 2023 through 2029. With Phenylketonuria Medications and Supplements sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phenylketonuria Medications and Supplements industry.
This Insight Report provides a comprehensive analysis of the global Phenylketonuria Medications and Supplements landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Phenylketonuria Medications and Supplements portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Phenylketonuria Medications and Supplements market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phenylketonuria Medications and Supplements and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phenylketonuria Medications and Supplements.
This report presents a comprehensive overview, market shares, and growth opportunities of Phenylketonuria Medications and Supplements market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Medications
Supplements
Segmentation by application
Household
Hospital
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biomarin
Mead Johnson
Abbott
Nutricia
Dr. Schär
Vitaflo
Cambrooke
PKU Perspectives
Firstplay Dietary
Key Questions Addressed in this Report
What is the 10-year outlook for the global Phenylketonuria Medications and Supplements market?
What factors are driving Phenylketonuria Medications and Supplements market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Phenylketonuria Medications and Supplements market opportunities vary by end market size?
How does Phenylketonuria Medications and Supplements break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
United States market for Phenylketonuria Medications and Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Phenylketonuria Medications and Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Phenylketonuria Medications and Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Phenylketonuria Medications and Supplements players cover Biomarin, Mead Johnson, Abbott, Nutricia, Dr. Schär, Vitaflo, Cambrooke, PKU Perspectives and Firstplay Dietary, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.
LPI (LP Information)' newest research report, the “Phenylketonuria Medications and Supplements Industry Forecast” looks at past sales and reviews total world Phenylketonuria Medications and Supplements sales in 2022, providing a comprehensive analysis by region and market sector of projected Phenylketonuria Medications and Supplements sales for 2023 through 2029. With Phenylketonuria Medications and Supplements sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phenylketonuria Medications and Supplements industry.
This Insight Report provides a comprehensive analysis of the global Phenylketonuria Medications and Supplements landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Phenylketonuria Medications and Supplements portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Phenylketonuria Medications and Supplements market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phenylketonuria Medications and Supplements and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phenylketonuria Medications and Supplements.
This report presents a comprehensive overview, market shares, and growth opportunities of Phenylketonuria Medications and Supplements market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Medications
Supplements
Segmentation by application
Household
Hospital
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biomarin
Mead Johnson
Abbott
Nutricia
Dr. Schär
Vitaflo
Cambrooke
PKU Perspectives
Firstplay Dietary
Key Questions Addressed in this Report
What is the 10-year outlook for the global Phenylketonuria Medications and Supplements market?
What factors are driving Phenylketonuria Medications and Supplements market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Phenylketonuria Medications and Supplements market opportunities vary by end market size?
How does Phenylketonuria Medications and Supplements break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Phenylketonuria Medications and Supplements Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Phenylketonuria Medications and Supplements by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Phenylketonuria Medications and Supplements by Country/Region, 2018, 2022 & 2029
2.2 Phenylketonuria Medications and Supplements Segment by Type
2.2.1 Medications
2.2.2 Supplements
2.3 Phenylketonuria Medications and Supplements Sales by Type
2.3.1 Global Phenylketonuria Medications and Supplements Sales Market Share by Type (2018-2023)
2.3.2 Global Phenylketonuria Medications and Supplements Revenue and Market Share by Type (2018-2023)
2.3.3 Global Phenylketonuria Medications and Supplements Sale Price by Type (2018-2023)
2.4 Phenylketonuria Medications and Supplements Segment by Application
2.4.1 Household
2.4.2 Hospital
2.5 Phenylketonuria Medications and Supplements Sales by Application
2.5.1 Global Phenylketonuria Medications and Supplements Sale Market Share by Application (2018-2023)
2.5.2 Global Phenylketonuria Medications and Supplements Revenue and Market Share by Application (2018-2023)
2.5.3 Global Phenylketonuria Medications and Supplements Sale Price by Application (2018-2023)
3 Global Phenylketonuria Medications and Supplements by Company
3.1 Global Phenylketonuria Medications and Supplements Breakdown Data by Company
3.1.1 Global Phenylketonuria Medications and Supplements Annual Sales by Company (2018-2023)
3.1.2 Global Phenylketonuria Medications and Supplements Sales Market Share by Company (2018-2023)
3.2 Global Phenylketonuria Medications and Supplements Annual Revenue by Company (2018-2023)
3.2.1 Global Phenylketonuria Medications and Supplements Revenue by Company (2018-2023)
3.2.2 Global Phenylketonuria Medications and Supplements Revenue Market Share by Company (2018-2023)
3.3 Global Phenylketonuria Medications and Supplements Sale Price by Company
3.4 Key Manufacturers Phenylketonuria Medications and Supplements Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Phenylketonuria Medications and Supplements Product Location Distribution
3.4.2 Players Phenylketonuria Medications and Supplements Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Phenylketonuria Medications and Supplements by Geographic Region
4.1 World Historic Phenylketonuria Medications and Supplements Market Size by Geographic Region (2018-2023)
4.1.1 Global Phenylketonuria Medications and Supplements Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Phenylketonuria Medications and Supplements Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Phenylketonuria Medications and Supplements Market Size by Country/Region (2018-2023)
4.2.1 Global Phenylketonuria Medications and Supplements Annual Sales by Country/Region (2018-2023)
4.2.2 Global Phenylketonuria Medications and Supplements Annual Revenue by Country/Region (2018-2023)
4.3 Americas Phenylketonuria Medications and Supplements Sales Growth
4.4 APAC Phenylketonuria Medications and Supplements Sales Growth
4.5 Europe Phenylketonuria Medications and Supplements Sales Growth
4.6 Middle East & Africa Phenylketonuria Medications and Supplements Sales Growth
5 Americas
5.1 Americas Phenylketonuria Medications and Supplements Sales by Country
5.1.1 Americas Phenylketonuria Medications and Supplements Sales by Country (2018-2023)
5.1.2 Americas Phenylketonuria Medications and Supplements Revenue by Country (2018-2023)
5.2 Americas Phenylketonuria Medications and Supplements Sales by Type
5.3 Americas Phenylketonuria Medications and Supplements Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Phenylketonuria Medications and Supplements Sales by Region
6.1.1 APAC Phenylketonuria Medications and Supplements Sales by Region (2018-2023)
6.1.2 APAC Phenylketonuria Medications and Supplements Revenue by Region (2018-2023)
6.2 APAC Phenylketonuria Medications and Supplements Sales by Type
6.3 APAC Phenylketonuria Medications and Supplements Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Phenylketonuria Medications and Supplements by Country
7.1.1 Europe Phenylketonuria Medications and Supplements Sales by Country (2018-2023)
7.1.2 Europe Phenylketonuria Medications and Supplements Revenue by Country (2018-2023)
7.2 Europe Phenylketonuria Medications and Supplements Sales by Type
7.3 Europe Phenylketonuria Medications and Supplements Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Phenylketonuria Medications and Supplements by Country
8.1.1 Middle East & Africa Phenylketonuria Medications and Supplements Sales by Country (2018-2023)
8.1.2 Middle East & Africa Phenylketonuria Medications and Supplements Revenue by Country (2018-2023)
8.2 Middle East & Africa Phenylketonuria Medications and Supplements Sales by Type
8.3 Middle East & Africa Phenylketonuria Medications and Supplements Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Phenylketonuria Medications and Supplements
10.3 Manufacturing Process Analysis of Phenylketonuria Medications and Supplements
10.4 Industry Chain Structure of Phenylketonuria Medications and Supplements
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Phenylketonuria Medications and Supplements Distributors
11.3 Phenylketonuria Medications and Supplements Customer
12 World Forecast Review for Phenylketonuria Medications and Supplements by Geographic Region
12.1 Global Phenylketonuria Medications and Supplements Market Size Forecast by Region
12.1.1 Global Phenylketonuria Medications and Supplements Forecast by Region (2024-2029)
12.1.2 Global Phenylketonuria Medications and Supplements Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Phenylketonuria Medications and Supplements Forecast by Type
12.7 Global Phenylketonuria Medications and Supplements Forecast by Application
13 Key Players Analysis
13.1 Biomarin
13.1.1 Biomarin Company Information
13.1.2 Biomarin Phenylketonuria Medications and Supplements Product Portfolios and Specifications
13.1.3 Biomarin Phenylketonuria Medications and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Biomarin Main Business Overview
13.1.5 Biomarin Latest Developments
13.2 Mead Johnson
13.2.1 Mead Johnson Company Information
13.2.2 Mead Johnson Phenylketonuria Medications and Supplements Product Portfolios and Specifications
13.2.3 Mead Johnson Phenylketonuria Medications and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Mead Johnson Main Business Overview
13.2.5 Mead Johnson Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Phenylketonuria Medications and Supplements Product Portfolios and Specifications
13.3.3 Abbott Phenylketonuria Medications and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Nutricia
13.4.1 Nutricia Company Information
13.4.2 Nutricia Phenylketonuria Medications and Supplements Product Portfolios and Specifications
13.4.3 Nutricia Phenylketonuria Medications and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Nutricia Main Business Overview
13.4.5 Nutricia Latest Developments
13.5 Dr. Schär
13.5.1 Dr. Schär Company Information
13.5.2 Dr. Schär Phenylketonuria Medications and Supplements Product Portfolios and Specifications
13.5.3 Dr. Schär Phenylketonuria Medications and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Dr. Schär Main Business Overview
13.5.5 Dr. Schär Latest Developments
13.6 Vitaflo
13.6.1 Vitaflo Company Information
13.6.2 Vitaflo Phenylketonuria Medications and Supplements Product Portfolios and Specifications
13.6.3 Vitaflo Phenylketonuria Medications and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Vitaflo Main Business Overview
13.6.5 Vitaflo Latest Developments
13.7 Cambrooke
13.7.1 Cambrooke Company Information
13.7.2 Cambrooke Phenylketonuria Medications and Supplements Product Portfolios and Specifications
13.7.3 Cambrooke Phenylketonuria Medications and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Cambrooke Main Business Overview
13.7.5 Cambrooke Latest Developments
13.8 PKU Perspectives
13.8.1 PKU Perspectives Company Information
13.8.2 PKU Perspectives Phenylketonuria Medications and Supplements Product Portfolios and Specifications
13.8.3 PKU Perspectives Phenylketonuria Medications and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 PKU Perspectives Main Business Overview
13.8.5 PKU Perspectives Latest Developments
13.9 Firstplay Dietary
13.9.1 Firstplay Dietary Company Information
13.9.2 Firstplay Dietary Phenylketonuria Medications and Supplements Product Portfolios and Specifications
13.9.3 Firstplay Dietary Phenylketonuria Medications and Supplements Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Firstplay Dietary Main Business Overview
13.9.5 Firstplay Dietary Latest Developments
14 Research Findings and Conclusion